Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea · Delayed Price · Currency is KRW 7,560.00
-140.00 (-1.82%)
At close: Apr 20, 2026
KOSDAQ:036480 Revenue
In the year 2025, Daesung Microbiological Labs. had annual revenue of 25.99B KRW with 9.18% growth. Daesung Microbiological Labs. had revenue of 6.92B in the quarter ending December 31, 2025, with 1.87% growth.
Revenue
25.99B
Revenue Growth
+9.18%
P/S Ratio
1.11
Revenue / Employee
193.95M
Employees
134
Market Cap
28.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.99B | 2.18B | 9.18% |
| Dec 31, 2024 | 23.80B | -1.76B | -6.88% |
| Dec 31, 2023 | 25.56B | 62.26M | 0.24% |
| Dec 31, 2022 | 25.50B | 1.50B | 6.26% |
| Dec 31, 2021 | 24.00B | -803.74M | -3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 99.01B |
| GeneBioTech Co. ,Ltd | 90.79B |
| Korean Drug | 62.51B |
| ChoA Pharmaceutical Co., LTD. | 59.31B |
| WooGene B&G | 54.76B |
| Seoul Pharma | 52.15B |
| Union Korea Pharm | 36.38B |
| BIFIDO | 19.68B |